In rats, enzymatic shedding of the glycocalyx is primarily induced by MMPs [158, 159]
for acute deficiency, treatment may continue until clinical signs resolve and laboratory values normalize
And people can experience an array of complications
We note that the Vivistim System was granted transitional device pass-through status on January 1, 2023, that is set to expire December 31, 2025
10.1016/j.bbi.2012.09.004 [DOI] [PMC free article] [PubMed] [Google Scholar] Leo R, Apolnio JD, Lee D, Figueiredo A, Tabori U, Castelo-Branco P (2018) Mechanisms of human telomerase reverse transcriptase (hTERT) regulation: clinical impacts in cancer
[25] Sen McAuliffe et al., Can ultrasound imaging predict the development of Achilles and patellar tendinopathy